Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa In The News.
Press releases published on August 7, 2025
Clearmind Medicine Announces Publication of International Patent Application for Novel Combination Therapy Targeting Obesity and High Blood Sugar
GlobeNewswire
·
August 7, 2025
Vancouver, Canada, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to …
InflaRx Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
INF904 Phase 2a data in chronic spontaneous urticaria (CSU) and hidradenitis suppurativa (HS) expected by the end of September to early November 2025 Phase 1/2 data announced by Staidson BioPharmaceuticals for InflaRx-partnered C5a antibody BDB-001 in ANCA …
Y-mAbs to Announce Second Quarter 2025 Financial and Operating Results on August 8, 2025
GlobeNewswire
·
August 7, 2025
PRINCETON, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”) (Nasdaq: YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the …
Cabaletta Bio Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
– Registrational cohort enrollment in RESET-Myositis™ trial on track to start in 2H25 with anticipated 2027 BLA submission for rese-cel in myositis – – Five disease-specific cohorts fully enrolled in the RESET™ clinical development program from over 70 …
Achieve Life Sciences Reports Second Quarter 2025 Financial Results; Provides Updates on Cytisinicline Program
GlobeNewswire
·
August 7, 2025
SEATTLE and VANCOUVER, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of …
Verano Announces Resignation of Company President Darren Weiss
GlobeNewswire
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced the resignation of Darren Weiss from his role as Company President to …
ProQR Announces Second Quarter 2025 Operating and Financial Results
GlobeNewswire
·
August 7, 2025
Submitted CTA for lead program AX-0810, targeting NTCP for cholestatic diseases Advancing AX-2402 program toward clinical candidate selection, targeting MECP2 (R270X) for Rett Syndrome Hosting fall Analyst and Investor Event (virtual), featuring detailed …
Ligand Reports Second Quarter 2025 Financial Results and Raises Guidance
GlobeNewswire
·
August 7, 2025
Second quarter performance driven by strong portfolio royalty revenue growth of 57% 2025 full year revenue guidance increased to $200 million - $225 million (previously $180 million - $200 million) and adjusted earnings per diluted share1 increased to $6. …
NexGold Intersects 23.73 g/t Gold over 5.3 Metres and 24.65 g/t Gold over 2.2 Metres at the Goldboro Open Pit Gold Project
GlobeNewswire
·
August 7, 2025
TORONTO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide additional drill results from a recently-completed 26,854-metre diamond drill program initially announced on …
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business Update
GlobeNewswire
·
August 7, 2025
RAP-219 Phase 2a trial in patients with drug-resistant focal onset seizures is fully enrolled and on track for topline results in September 2025 Phase 2 trial of RAP-219 in bipolar mania has been initiated and is enrolling patients; trial remains on track, …
Aya Gold & Silver Receives US$8 Million in Compensation Related to Zgounder Expansion
GlobeNewswire
·
August 7, 2025
MONTREAL, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Aya Gold & Silver Inc. (TSX: AYA; OTCQX: AYASF) (“Aya” or the “Corporation”) announces that its subsidiary, Zgounder Millenium Silver Mining (“ZMSM”), has received a payment of approximately US$8 million under …
Cormedix Inc. Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
August 7, 2025
‒ Q2 2025 Net Revenue of $39.7mm; Net Income of $19.8mm; Adjusted EBITDA of $22.4mm ‒ ‒ Company Announces Acquisition of Melinta Therapeutics ‒ ‒ Conference Call Scheduled for Today at 8:30 a.m. Eastern Time ‒ BERKELEY HEIGHTS, N.J., Aug. 07, 2025 (GLOBE …
Surge Copper Announces Commencement of 2025 Field Program at Berg Project
GlobeNewswire
·
August 7, 2025
Vancouver, British Columbia, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to provide an update on its 2025 field program, which commenced in mid-July at the Company …
HUTCHMED Reports 2025 Interim Results
GlobeNewswire
·
August 7, 2025
— Indications expansion driving growth and ATTC platform enriching pipeline — — $455 million in net income attributable to HUTCHMED driven by non-core partial disposal — HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Aug. 07, 2025 (GLOBE NEWSWIRE) -- …
XORTX Provides Corporate Update and Planned Activities for 2025 / 2026
GlobeNewswire
·
August 7, 2025
CALGARY, Alberta, Aug. 07, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …
CorMedix to acquire Melinta Therapeutics, Creating Diversified Specialty Company With Strong Presence in Acute Care Settings
GlobeNewswire
·
August 7, 2025
Transformational deal for CorMedix that expands and diversifies company’s commercial product portfolio, with seven innovative drug products and a pipeline expansion indication with near-term revenue growth potential Transaction expected to be near-term …
Verano Announces Second Quarter 2025 Financial Results
GlobeNewswire
·
August 7, 2025
CHICAGO, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNOF) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced its financial results for the second quarter ended June 30, 2025, which …
MEXC July Token Listings Surge to 35,920% Peak Returns as AI Infrastructure Dominates Market
GlobeNewswire
·
August 7, 2025
VICTORIA, Seychelles, Aug. 07, 2025 (GLOBE NEWSWIRE) -- MEXC, a leading global cryptocurrency exchange, has released its comprehensive July 2025 Market Performance Report, highlighting exceptional token performance fueled by AI infrastructure adoption and …
Accumulus Synergy gliedert Accumulus Technologies aus, um bewährte Regulierungsplattform zu skalieren und den globalen Zugang zu Therapien zu beschleunigen
GlobeNewswire
·
August 7, 2025
BURLINGAME, Kalifornien, Aug. 07, 2025 (GLOBE NEWSWIRE) -- In einem richtungsweisenden Schritt zur Förderung regulatorischer Innovationen und zur besseren Deckung der weltweit steigenden Nachfrage hat Accumulus Synergy, ein gemeinnütziger Branchenverband, …
Accumulus Synergy crée Accumulus Technologies pour développer sa plateforme réglementaire éprouvée et accélérer l’accès mondial aux thérapies
GlobeNewswire
·
August 7, 2025
BURLINGAME, Californie, 07 août 2025 (GLOBE NEWSWIRE) -- Dans une démarche audacieuse visant à accélérer l’innovation réglementaire et à répondre à la demande mondiale croissante, Accumulus Synergy, une association professionnelle à but non lucratif, a …